Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug

All NewsAugust 5, 2025

Quantum Biopharma’s subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent